Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet

Ezetimibe (EZE) possesses low aqueous solubility and poor bioavailability and in addition, its extensive hepatic metabolism supports the notion of developing a novel carrier system for EZE. Ezetimibe was encapsulated into nanostructured lipid carriers (EZE-NLCs) via a high pressure homogenization te...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Yogeeta O., Mahajan, Umesh B., Agnihotri, Vinit V., Nilange, Mayur S., Mahajan, Hitendra S., Sharma, Charu, Ojha, Shreesh, Patil, Chandragouda R., Goyal, Sameer N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967240/
https://www.ncbi.nlm.nih.gov/pubmed/33803259
http://dx.doi.org/10.3390/molecules26051485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967240/
https://www.ncbi.nlm.nih.gov/pubmed/33803259
http://dx.doi.org/10.3390/molecules26051485

Ejemplares similares